BNP Paribas Financial Markets’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-4
| Closed | -$1 | – | 3790 |
|
|
2019
Q4 | $1 | Buy |
4
+2
| +100% | +$1 | ﹤0.01% | 3750 |
|
|
2019
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 3903 |
|
|
2019
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 3946 |
|
|
2019
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 3730 |
|
|
2018
Q4 | $1 | Hold |
2
| – | – | ﹤0.01% | 3645 |
|
|
2018
Q3 | $2 | Hold |
2
| – | – | ﹤0.01% | 3764 |
|
|
2018
Q2 | $2 | Hold |
2
| – | – | ﹤0.01% | 3762 |
|
|
2018
Q1 | $4 | Hold |
2
| – | – | ﹤0.01% | 3619 |
|
|
2017
Q4 | $2 | Hold |
2
| – | – | ﹤0.01% | 3537 |
|
|
2017
Q3 | $3 | Hold |
2
| – | – | ﹤0.01% | 3561 |
|
|
2017
Q2 | $3 | Sell |
2
-32
| -94% | -$48 | ﹤0.01% | 3601 |
|
|
2017
Q1 | $63 | Buy |
+34
| New | +$63 | ﹤0.01% | 3428 |
|
|
2016
Q4 | – | Sell |
-1,824
| Closed | -$10.2K | – | 3520 |
|
|
2016
Q3 | $10.2K | Buy |
1,824
+877
| +93% | +$4.89K | ﹤0.01% | 3163 |
|
|
2016
Q2 | $5.26K | Buy |
+947
| New | +$5.26K | ﹤0.01% | 3250 |
|
|
2016
Q1 | – | Sell |
-4,094
| Closed | -$24.6K | – | 3300 |
|
|
2015
Q4 | $24.6K | Buy |
4,094
+757
| +23% | +$4.56K | ﹤0.01% | 3219 |
|
|
2015
Q3 | $26.1K | Buy |
3,337
+1,937
| +138% | +$15.1K | ﹤0.01% | 3223 |
|
|
2015
Q2 | $8.58K | Buy |
+1,400
| New | +$8.58K | ﹤0.01% | 3365 |
|
|
2014
Q3 | – | Sell |
-308
| Closed | -$2.39K | – | 3778 |
|
|
2014
Q2 | $2.39K | Hold |
308
| – | – | ﹤0.01% | 2526 |
|
|
2014
Q1 | $2.01K | Hold |
308
| – | – | ﹤0.01% | 2225 |
|
|
2013
Q4 | $1.85K | Buy |
+308
| New | +$1.85K | ﹤0.01% | 3172 |
|